urlscan.io logo urlscan.io
SecurityTrails logo

www.cvs.com Open in urlscan Pro
23.205.60.109  Public Scan

Go To Rescan Add Verdict Report
Submitted URL: https://protect-us.mimecast.com/s/MWdhCR6DLGfgWwgRvC28OCb?domain=cvs.com
Effective URL: https://www.cvs.com/%7B%7BstudyURL%7D%7D
Submission: On November 02 via manual from US — Scanned from US
 Behaviour Indicators
Similar DOM Content API
Verdicts

Summary

This website contacted 2 IPs in 1 countries across 2 domains to perform 14 HTTP transactions. The main IP is 23.205.60.109, located in Edison, United States and belongs to AKAMAI-AS, US. The main domain is www.cvs.com. The Cisco Umbrella rank of the primary domain is 9851.
TLS certificate: Issued by DigiCert SHA2 Secure Server CA on September 2nd 2022. Valid for: 10 months.
This is the only time www.cvs.com was scanned on urlscan.io!

urlscan.io Verdict: No classification

Domain & IP information

IP Address AS Autonomous System
2 2 207.211.31.106 14135 (NAVISITE-...)
10 23.205.60.109 16625 (AKAMAI-AS)
14 2
Apex Domain
Subdomains		 Transfer
10 cvs.com
www.cvs.com — Cisco Umbrella Rank: 9851
depservices.cvs.com — Cisco Umbrella Rank: 61845
158 KB
2 mimecast.com
protect-us.mimecast.com — Cisco Umbrella Rank: 20305
8 KB
14 2
Domain Requested by
8 www.cvs.com www.cvs.com
2 depservices.cvs.com www.cvs.com
2 protect-us.mimecast.com 2 redirects
14 3

This site contains no links.

Subject Issuer Validity Valid
www.cvs.com
DigiCert SHA2 Secure Server CA		 2022-09-02 -
2023-07-01		 10 months crt.sh

This page contains 1 frames:

Primary Page: https://www.cvs.com/%7B%7BstudyURL%7D%7D
Frame ID: 5ED8024C557303ABA3283C08F1CE0C25
Requests: 13 HTTP requests in this frame

Screenshot
Live screenshot
Full Image

Page URL History Show full URLs

  1. https://protect-us.mimecast.com/s/MWdhCR6DLGfgWwgRvC28OCb?domain=cvs.com HTTP 307
    https://protect-us.mimecast.com/r/p3E_Wxk4Yyc4ABacMaXxxhgghMNAQbgj43QIubHyxzhtHeAyYDJ5WRhiC5miOfN3rTNl8U19xj... HTTP 307
    https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7Bopportunity... Page URL
  2. https://www.cvs.com/%7B%7BstudyURL%7D%7D Page URL

Detected technologies

Overall confidence: 100%
Detected patterns
Overall confidence: 100%
Detected patterns
  • moment(?:\.min)?\.js

Page Statistics

14
Requests

71 %
HTTPS

0 %
IPv6

2
Domains

3
Subdomains

2
IPs

1
Countries

158 kB
Transfer

490 kB
Size

69
Cookies

Page URL History

This captures the URL locations of the websites, including HTTP redirects and client-side redirects via JavaScript or Meta fields.

  1. https://protect-us.mimecast.com/s/MWdhCR6DLGfgWwgRvC28OCb?domain=cvs.com HTTP 307
    https://protect-us.mimecast.com/r/p3E_Wxk4Yyc4ABacMaXxxhgghMNAQbgj43QIubHyxzhtHeAyYDJ5WRhiC5miOfN3rTNl8U19xj6ZNZo6PmEqpzUPhR9Ryv86Yi0mjjp3QRYfFI3S62WvsOt3zcLd0qrngAgakHab4IR6GMuvoMaGjgk3aHaJEKWm-H6rJ1a0uRssKul9q4qxW9-ZYvvofm93fT8TAgxvavFPs9D4DIXfH8VTfhP59G3Ne7fKqhLpaat3X82ZnBNduvcY0NRDkNuiy3ry-sBiLece4SnVEBnyWWVp6mh4oetv7Sq6sJqpoQ6EUPrY4ZMNxvi11Pg4ICR-_h1XJlwEUlU4v8EOlnx0J7z4HNoDl-7sJJaP-f1Ln1i8cRFMNIlYZJV7LBTBTjRYwPq0MG5Sfi5Gm-0711CJ13tpcfsW_pdAcLD-5d_XRojB6WsQwq4kfYu5qGeweA41NUAkL1bSRGKjzmmoVN9RfBBtPuhE9zsAPU4tVC2qiPyd7o4pAvD8WvBk-FW1NOoDsVSWLHpdwfUhvtXQiwiOTi-vCWpqh8L_Dp_SRCDUhMkM1kyR6NFuDFA65xDpDT_I7YymBKXwp_Be_vbtFDO-9cVAcl06bMPDt59K0yg_aMixicjscCeYCPBYs-TXgpNlPrwYd_sI4l4YBjO-ZBRRGdwB19-Pz05sczpOaYdreDCfRO_DDHLUvdKN775073vaaUGava1mis95wCDKYaM5glXa9m2hAQqmLkjtxzShE-J-UBHjiRdUEreFltD75LjBtkEIAOlzPCNTuOR44uCnNANbc66HsXl7lfj051skCpaQV-wOBEg6bhfDEQwuW7AXS35fAE7if_ZSwDRIjgNW97-La-CcOwIMSciBqD4_W2Xr4Y-t5dfBuQ31GaSa-rh8jbuG3l86imzb2PdiHss8sKhRpgi6e9Sk3fta-3dOMBjTGHM_bRUllhDHT5qmuTuDaC8k7Ln9aXXeKCI7waRen-Xs-9AiD-GfjFPWtAfwgvFiQBNfO82et01n-uer9y0O51BCVs-46MMLQAfmXlCi-uaiwaiEsGlRuaO9iI002C7S1TdMjRRZOsnTvwpD4A9QtAUbTg8xVgekl7GyvSGMp1Anho6pUfmVORUVYqulA2ZU0VNIX-UN0RnrmNNN2nd-8FrjypXWN3lsj3ojyMzlIN94ClSIngeX9sycjGB51wsZ-BDLEfdXQP9IdDaX1Mk95wepoaQqcgJfmn_OSkqivYb_t4W0_w9wrDRJmpvAt18SHDAjlLVKTCw1v-Boa0S9-VINgYfKatCHOTdKnlsh6CiKjZjn62hGKSSjh9pquJ30VSGRMAYGxEGKi0pga7QmHrDzemnEwj1FxMqS0cB8I0jn1VlEDQ6qBfktKYk0LG9CHSwG0Aeh_xLFGEBJCieUmJUN8ClFVXjQ5CgKz0dQC4Jd2rF7s_ORA3v9DrF1_1OKJZ5LM8auOGLPU0ARyoIuRCybzwOlY5NFOVnadmQY8pBqe24f_Bo_MZLAyz_XFPb_-h5Am3X31pB7RGBd4zZD_iJr0s6yDIXqRQs1hMUTvhrz1F0MI8o8VWl9e5foyOm830Xdiv1IQvIMlgoQ13jLQcfEHeLnNY1xlmA1UJfQx4HXMtYum1EEKn7IdzvH2wKfYpwoxxlO25DrH39_eWphf3oGUl-lmiF2OGuk9ZZ1l12NHTGakx-azsIOGenF3fcXiTgNZD5pmD1xFVe37kur1lCNVvZNc50MffdNdevFSs3GmydYktJ97rqi697rDEmg3R-L0Qiebi8UMAHOdGvK3lOEuiYs9ve2p7Hw__m1-HtskifuHPPDyt1sBQocWOKJWuNftoFx7U3eUUuh1chvoKG4VhYrGniMLPISL-4iJ3afhTbsenbSdQT-RiShAD4za2qyyGJ5RgxUCAlD3glCLYqfB1ICncw3g4iunR-ielAN94qB9PFFLk3YHmhJEGSdzLhIu1fxqG7mTFW436vMmFeDC3UAbMUBHHuMZHaPiGbxJ2oLEdF0RSJFqbNH0Hh-ymB8sOlVgSJ1ZDhagBMgyQ1yiPwb6m1oM1Pp4u7fEg1TJ7vdILERgxwVKmT4vUfGj_IS6A59TfATrFsXFcxztayPxK7FmQtYZ4Hv0UWAfIO4afefosdt-ERItRvSps9iNDQAi8CleY4hUGW-3HQiJ5SGoDMck4QOA-cfCD8vEPNup6Vj-iCFgK4AjxdUfwFryqak2_iB5tBT6sfQE5Qyer5pIQiw3Su9UDo8xK2OHKufFThHABEb_s2EivMRJMoPDRR4XE6PWZEta1gf_REsuDhwkT1owR0Q5KsPtTuDb5i0Bh4qbPMloieJTSbWOEceGHCTJznQM3Ftu6yC5yQD2yYm99D9lPm23UOSRXONVUVgq1AT1Mkoc1OYzwtHiV4hMiUVlaLxA9Q2tXpX1D5orV9SreOCIn5zID89kAbqgAB-ytb7KZpO8n4a88s7uLAu2Wqu-r5DFv1M10GjhKvcSDExyhjL3F9VABU0xFSALsA_98HsyWq9FqgFaaeK_qg50SWwDfi13p1--vgJWpNokLFSC5BEOtPK7d7Xu93cXrPcRHpITfUPUmMxDstWaS9_EjzFqEMs66KSnMxl360VpOeur8nyu4G7b_JrIIdoORWS_3IaCJi_boMj0iELnQzeYOuwjZjhw5AvGpg5fXt4fl032V_VF4nyCGDO6B3ACWeNf2BA073DVdNtataj3951pMRy3qcxxyDJ6zCwOI7WmSvAVZofffJ0bL0ImV9VeY69KbANrgrGYO7IX0vcLNh79pEGGxwQ-uO_HBb7b07byLA8CkUx64FtpytLRUdCC2yQii6QO9K-CH0IOaILJD_xV2L2Nm7WO4lLX4RpkZCuL8dFGi1dwRNw06bt_GbrAMKZFPi3XGmejutW_1wgvEpcymFNO064H9EeZbIjaROgIbY41sxvoK7xVskXsKe-3FHp3VAMNnrQiRjZQyBCIEprll8xSTxDo9BSstPPOOGdnX9wD-lBjgI6UZUVje7lkF8FIP0iB_1CY8ndDVLZf6VLJpnzdLDXklzRmMxJSIygmnEMwNVYy_4sLXn1Di3UgHEamgW1JhBPUBwKq2Rx9DMGkUPgdoA1hVOb_r-ITOushnq26jCCQ-q2W3-VckMGy-hox5P3QYlfRpaa4XYop75q1_mcqkPG87AaN5yLqkfjNw96tRuoK2pMJ4XmzV_gVoe2LBissNagHHfu0q55Fh4CG7J3Nm9OGg2OaYgRQjYgujzvRJ3Cf26_SKhxNH5835Ohh6XEJUvnuUtrMJMCI8w7LS7YBtkuLWxItVqzKcFLJ5hk7P-E99R2bgGjtDsOHOvd1kEf_RT--KtvGJtplIEsq3pqhhmTgc8r2LlNpdXudtbzLnfTTUBqkaW18VqOrkmhK7uRMe-UbF6Ia_lvyNHlFSmT64MjIwhEw786Wc7DknouSg-aHJPsuSWYVfjegQRsFMbZZudpjilKv3k9_hxgccc28E06Aidgq01kM1krr2cP9mmqU8z35MY1KcbU2L4klaFiaPTeviZbFGz24DMMUgj_fHhFCff77tMBP8y-lFIKf7bezH8NZgPahH1xV6JGLPhVBv0L3S4rdfZwvh6cjX3BdIu16hFwGiqaq7-LxbpT8fecsuRfIViretFeDx8JOXFKADrYKF_KJreyJDojmiD5DUlYSwlF9RErOlG8XH1qRB2BiA4QYP2Q7Jhd_A4pdlKlS57Cw69hvSbXV9aQNpGWocPqql1sfIvwTWslHQHR084E0vbKjoBm1XeNNuCUkZsSjryDVCiNx34mi71w27w_olzACU3ikOCjzqWv-JTDTi7m_LRMETkL9XNvhNwaqgg1DFBYeq8tcJCa-ju9yeTuQLHi2xlE1OBaktanAsatyH1XxMV8JwRyOQM0PmWEIajPFlw0uPsl3Jsv5gwCxUZ7HbJjnoqaY30GcI_CRfRHFdKadBaZuNA5ij5tYSEPrB3T-bJ-0F3M4O_CMppb1uP3vxO1mSbFDT19bgkbdlCixWS_vNDszcK-8eUGZaAX8ykHjqPQuTU3YLpu4x5t-Sj8wZlHyHCdYC0hp0YwrA_BNx8QKBXrY8MackI0oOYqBif6YPcTG44KZZ8puYckVndhwwg7REwIfHjuOJTpbYiZVNS05cGK3R-iriu8L8bFXa54El-s0D7pK9uqtt99sJwgjZb1m2XYTd0m4F8RP1BLlImU0YWLC_v-wgH5eiaz7hk4YKUw6-1otbAh1L4f_nCHn_O_0fm-YPmAr4w31y5nsLG-nMs8MZuQRdco4M_HwNnypZ3sW0lRqmIfM-U2u1YRaV43zxIP3GqYS-Qu0mu_o-QG_I3_yiUoyxjMOaGctU3CY-43r-aHKuMBdkm9zbDMe6PDv_bcAibs5bWY_OkFBuEHDpq1PD34TQ826kJ5SE1bsnBvICDOWbX1GfZluhWzerSWfa1oEi4q-FMFbrfTBDQ3vJrcZ7CJaBL-6gWtLWlQGx0vhUxDE6Q_Gi9TV1q5EYab_i1XEnVE5E4UKVfZK3pYGyWalK7DcVjCgnZh3JmTKbf5eVg0pZN2kCFjwRsX0fUJTiHIRlFficbwKgeWDdPqZc1O3wOAsM0z_f4Yj6CgOsob5zwZJ0CTxHTGb7gfTqPMc_YIOAANUikc16kdbvxmd6947wB04CCcVrf44n4YTvDs9fyY5_NPb3CDpFEGftEtssk50XrFVA6p0vin3PtdCEExibxul2KKFge7gRJp2s4nHx_iIx1igbu29hgwuvdjiFN2GzRMlC1hFgeueEdwJWWeB7k9DE14revWV2MUGeZXmB8Yg-S7M9rws2pNE7E38iDOQveY-OExIWQvmNleMCX-MWPnhHfZIMIRUvIby1i3JlZZnhoQctHVJ9IAiewQmnURD_9fb-SWXIkMgVh3U9TpFtn4iDKFTwX-lyM0zKUfCs1d-k2o5mlTGOjoc4n80eG_oQSWRZ5N8iul8M_5OFAOliuK0sxL0NoZfdWwwEePMjn4FL3xaUwMR3SHtDI2asq1lQN1cdVn38-cBJmbWbk94L4zch5A00sV3WP9js1nCC_vcju5-BC70_ZypXXKjL5-uzI3RysWLAlFZO2ZE8zj6yCCxj80mixHSbtKpSDG39aOUbg6pjK8lBesMG-QYQwCZ2ZYAerl1C-wXIoCi2B25BPWLosZodvJC8aexwOOKWc0zHpHNbF2vmijaVIE7FehsEzP_SI8yd__Af9c5A5T-hRfmXZw2iMJk9JreAjEyO-kQZkdASbbEwhpRHJWWcH1Ivgx5sn9S2SaJKWZbNR9SzWSNEqS1Da_79cKT8DXqyq4yCnFt7CXX19p2p2Yd-Sp_9DTqouivThBJPk-ijzljluTFC5n4Ha_DQB85zMaYKBtriVNzA3ToBjGO6KmzsHu4xaP5Bqp_0unc7DWH_AtBI15suNkvMIbLPDUL6erpQIluFjnxBGtv4Pxmtizk4hWll7Sz0lXmAF-c4p5HlDHfwYzTDin9M8yJ3p6NiPbjOhg7sxYjfsGRdpLvA78ZYGaZpU62k9ZouAAGp1O7MMwgEoQRFiksW2mA0Kj2d7Kzba-ezRLGdGeJRDl7Bh3WLQ6ZK12nu5KlcbH5acKy_aTYU46Ui1ubz2Q-2g3tlDLStDm9bOta_Qc2iOX8igPSyE8h0tb74ZAm9GVv3Wg_JMvcOvY0uOQTg-ys4mbbFo-E8F_jno1Q389_OqZ5VmTr4b_u_zdEh3aYHEW67bACTeqgfwtb7wH4l-MaCwNgJfyvnvbP5GMXNqthzCntm-rfdXRA-K1cjSNn0LC9wnGhMC3iLqJbJKfXOXeMyUL6l8g_nux29eRxUv2Bc9TAv1_-ltbIAyNiawzeZKw9XYGUP4YLll9tMpoQaj8GlKo3s9j9KuGrTMn8qZBEEemtakm1DC4pLQL4Zt5mupn79y_B1jYk74jWz6xvbfeRSt4j2xIzXggdfvMDIYACQ5y-4PKc72pLAN3JjkHmYT_LHc7K7emkknHL-YFI7Nl7f6WA87JbLn0csg4SLyiJmlaadqx0LhZUZTr89DN8I23JUgHFo56x7MrAbOM7yVw4Lokd6i5_6QGYM_M5X9FklnRLM43-sOpDLAIgsgIRN0W65EUNYlp73WbHce_dUSFXNnz5JtFv_BORlmjMDZ_0qSXcYlop17R3OL_wyuYlMvtq17tYQcl7S0kewyX_9kuASnL2a8ht0UIpp7OuPwvUCXSIWwmdlaULT3mSJ-n8NHB_uTg00-JxjCRiEsKVlRkTJ1qRfY4qf86x-aiV59I0S1eUfQH1t4jsKYcVu3dKDW0jj_x6nIXfEg-sS3Do4EWvvZqrcjM1RE9sHaz3TVcCwbvTuLjEiEuAUwExF-5CS9kdW5TVRy6pN9es6gNKvUU7NY2QjIQg_LUSMtaA73Bj86BsGnQE7jC1Xlgv5YW97mi5n1hskqZzecycyCYXeeDaE_vYKOUU47wZA7LEdUYIQwcgZNuLpYbf9MKSHk2T-PyaCLiZ__y8nDcfvSHNChBM-E-HI2hbsuH5Zbq7wCZ7ZPHrcl68iSFVzNDlNgQsTSuTo9i5uzWT0y8xU3p1VmnC8Ayo298kYiNaTSzX0N5lX3sQcp8UTgdzfT8R99dpQgEWuwjBwOsvTJbyk_cOXhkMWCjLIQLnI47SsUqmeO9TQ9BZNu0a3UbnLVgqb3Url2NJxTG9FGTpUd4uQ3ebfELsF-7sZGa1CGI5iPH_qoeOHuffJxCqe-gAmERI-4VCSXcmKhznCLnloj36vwpVrUD871YkuxV59nxNgYiPdg3MykxQZYnaOjanDt5WLUbR-xS_EJyD7ndnjfP4MnTgeo5XiHGoqE3K5BaIj2S1G1tU6jivaVrN1HWZ6KnRkTb6wEsf1g_AS5I4Mg43HNdkHS8WDT2tMkkLZDqvsTPLp2BF43nrDp77YfxsmJFUqYlaiI3zrwtumby3TaaXYEgV2MP9dkoupiXF02yaz9Ntq6_IIl87prlVRD0GK_shuVKfzYhDm2YFOo0VyW-gv2jKkF6WZ97LIkmlqwsLiH8PwXgUYOv-XdV4GrnV4vA3IX7EbXhZCzPU0u9tvm01oq_7SDpO6PV4cIDWfJT22iTis6DH0CB6YDw6lOsbkY16usgTHEy5vHL0iEs6-Sp1rC-Kk-iNI1llNAVKkc4TZ0TD1tAjfe9dt1O5gbuPpFOKQ-el1yarJIsS70qaKpyleHCS5FsLhh4peKv5SbJiBQ1-VEa0JJjKBPSiz9uKAACrnnNN8UlW4lUxpxDHpgsd-nXaA6hsDH4f75aX15vT_zWsIW7T76vGcblU9x64RIUQFRdEAxiAdrp5djv1ZJIkrWtMLm1mEevGc2EFL9F8O5sKfeWmAPo4LqhkOw6OO1E0upcamWJJqFZmid5_eFMXrRcl3LbCNV68aUsTPimwSrdqbhMcIJuVfVyi9oo7LOV9XNrhYkyg0Jv86PPkOnKEzKxiJ0CZXs7YZT-LVNfCDe0Ab5EtzVEV_ifAjVfBGtVsImS_1l0J6-bl01NTpLBwN8BxO0_T8u4EPP7Q9zZjz_lk3-cXwcCsvCSVoj3Z0YJpuxM HTTP 307
    https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D Page URL
  2. https://www.cvs.com/%7B%7BstudyURL%7D%7D Page URL

Redirected requests

There were HTTP redirect chains for the following requests:

Request Chain 0
  • https://protect-us.mimecast.com/s/MWdhCR6DLGfgWwgRvC28OCb?domain=cvs.com HTTP 307
  • https://protect-us.mimecast.com/r/p3E_Wxk4Yyc4ABacMaXxxhgghMNAQbgj43QIubHyxzhtHeAyYDJ5WRhiC5miOfN3rTNl8U19xj6ZNZo6PmEqpzUPhR9Ryv86Yi0mjjp3QRYfFI3S62WvsOt3zcLd0qrngAgakHab4IR6GMuvoMaGjgk3aHaJEKWm-H6rJ1a0uRssKul9q4qxW9-ZYvvofm93fT8TAgxvavFPs9D4DIXfH8VTfhP59G3Ne7fKqhLpaat3X82ZnBNduvcY0NRDkNuiy3ry-sBiLece4SnVEBnyWWVp6mh4oetv7Sq6sJqpoQ6EUPrY4ZMNxvi11Pg4ICR-_h1XJlwEUlU4v8EOlnx0J7z4HNoDl-7sJJaP-f1Ln1i8cRFMNIlYZJV7LBTBTjRYwPq0MG5Sfi5Gm-0711CJ13tpcfsW_pdAcLD-5d_XRojB6WsQwq4kfYu5qGeweA41NUAkL1bSRGKjzmmoVN9RfBBtPuhE9zsAPU4tVC2qiPyd7o4pAvD8WvBk-FW1NOoDsVSWLHpdwfUhvtXQiwiOTi-vCWpqh8L_Dp_SRCDUhMkM1kyR6NFuDFA65xDpDT_I7YymBKXwp_Be_vbtFDO-9cVAcl06bMPDt59K0yg_aMixicjscCeYCPBYs-TXgpNlPrwYd_sI4l4YBjO-ZBRRGdwB19-Pz05sczpOaYdreDCfRO_DDHLUvdKN775073vaaUGava1mis95wCDKYaM5glXa9m2hAQqmLkjtxzShE-J-UBHjiRdUEreFltD75LjBtkEIAOlzPCNTuOR44uCnNANbc66HsXl7lfj051skCpaQV-wOBEg6bhfDEQwuW7AXS35fAE7if_ZSwDRIjgNW97-La-CcOwIMSciBqD4_W2Xr4Y-t5dfBuQ31GaSa-rh8jbuG3l86imzb2PdiHss8sKhRpgi6e9Sk3fta-3dOMBjTGHM_bRUllhDHT5qmuTuDaC8k7Ln9aXXeKCI7waRen-Xs-9AiD-GfjFPWtAfwgvFiQBNfO82et01n-uer9y0O51BCVs-46MMLQAfmXlCi-uaiwaiEsGlRuaO9iI002C7S1TdMjRRZOsnTvwpD4A9QtAUbTg8xVgekl7GyvSGMp1Anho6pUfmVORUVYqulA2ZU0VNIX-UN0RnrmNNN2nd-8FrjypXWN3lsj3ojyMzlIN94ClSIngeX9sycjGB51wsZ-BDLEfdXQP9IdDaX1Mk95wepoaQqcgJfmn_OSkqivYb_t4W0_w9wrDRJmpvAt18SHDAjlLVKTCw1v-Boa0S9-VINgYfKatCHOTdKnlsh6CiKjZjn62hGKSSjh9pquJ30VSGRMAYGxEGKi0pga7QmHrDzemnEwj1FxMqS0cB8I0jn1VlEDQ6qBfktKYk0LG9CHSwG0Aeh_xLFGEBJCieUmJUN8ClFVXjQ5CgKz0dQC4Jd2rF7s_ORA3v9DrF1_1OKJZ5LM8auOGLPU0ARyoIuRCybzwOlY5NFOVnadmQY8pBqe24f_Bo_MZLAyz_XFPb_-h5Am3X31pB7RGBd4zZD_iJr0s6yDIXqRQs1hMUTvhrz1F0MI8o8VWl9e5foyOm830Xdiv1IQvIMlgoQ13jLQcfEHeLnNY1xlmA1UJfQx4HXMtYum1EEKn7IdzvH2wKfYpwoxxlO25DrH39_eWphf3oGUl-lmiF2OGuk9ZZ1l12NHTGakx-azsIOGenF3fcXiTgNZD5pmD1xFVe37kur1lCNVvZNc50MffdNdevFSs3GmydYktJ97rqi697rDEmg3R-L0Qiebi8UMAHOdGvK3lOEuiYs9ve2p7Hw__m1-HtskifuHPPDyt1sBQocWOKJWuNftoFx7U3eUUuh1chvoKG4VhYrGniMLPISL-4iJ3afhTbsenbSdQT-RiShAD4za2qyyGJ5RgxUCAlD3glCLYqfB1ICncw3g4iunR-ielAN94qB9PFFLk3YHmhJEGSdzLhIu1fxqG7mTFW436vMmFeDC3UAbMUBHHuMZHaPiGbxJ2oLEdF0RSJFqbNH0Hh-ymB8sOlVgSJ1ZDhagBMgyQ1yiPwb6m1oM1Pp4u7fEg1TJ7vdILERgxwVKmT4vUfGj_IS6A59TfATrFsXFcxztayPxK7FmQtYZ4Hv0UWAfIO4afefosdt-ERItRvSps9iNDQAi8CleY4hUGW-3HQiJ5SGoDMck4QOA-cfCD8vEPNup6Vj-iCFgK4AjxdUfwFryqak2_iB5tBT6sfQE5Qyer5pIQiw3Su9UDo8xK2OHKufFThHABEb_s2EivMRJMoPDRR4XE6PWZEta1gf_REsuDhwkT1owR0Q5KsPtTuDb5i0Bh4qbPMloieJTSbWOEceGHCTJznQM3Ftu6yC5yQD2yYm99D9lPm23UOSRXONVUVgq1AT1Mkoc1OYzwtHiV4hMiUVlaLxA9Q2tXpX1D5orV9SreOCIn5zID89kAbqgAB-ytb7KZpO8n4a88s7uLAu2Wqu-r5DFv1M10GjhKvcSDExyhjL3F9VABU0xFSALsA_98HsyWq9FqgFaaeK_qg50SWwDfi13p1--vgJWpNokLFSC5BEOtPK7d7Xu93cXrPcRHpITfUPUmMxDstWaS9_EjzFqEMs66KSnMxl360VpOeur8nyu4G7b_JrIIdoORWS_3IaCJi_boMj0iELnQzeYOuwjZjhw5AvGpg5fXt4fl032V_VF4nyCGDO6B3ACWeNf2BA073DVdNtataj3951pMRy3qcxxyDJ6zCwOI7WmSvAVZofffJ0bL0ImV9VeY69KbANrgrGYO7IX0vcLNh79pEGGxwQ-uO_HBb7b07byLA8CkUx64FtpytLRUdCC2yQii6QO9K-CH0IOaILJD_xV2L2Nm7WO4lLX4RpkZCuL8dFGi1dwRNw06bt_GbrAMKZFPi3XGmejutW_1wgvEpcymFNO064H9EeZbIjaROgIbY41sxvoK7xVskXsKe-3FHp3VAMNnrQiRjZQyBCIEprll8xSTxDo9BSstPPOOGdnX9wD-lBjgI6UZUVje7lkF8FIP0iB_1CY8ndDVLZf6VLJpnzdLDXklzRmMxJSIygmnEMwNVYy_4sLXn1Di3UgHEamgW1JhBPUBwKq2Rx9DMGkUPgdoA1hVOb_r-ITOushnq26jCCQ-q2W3-VckMGy-hox5P3QYlfRpaa4XYop75q1_mcqkPG87AaN5yLqkfjNw96tRuoK2pMJ4XmzV_gVoe2LBissNagHHfu0q55Fh4CG7J3Nm9OGg2OaYgRQjYgujzvRJ3Cf26_SKhxNH5835Ohh6XEJUvnuUtrMJMCI8w7LS7YBtkuLWxItVqzKcFLJ5hk7P-E99R2bgGjtDsOHOvd1kEf_RT--KtvGJtplIEsq3pqhhmTgc8r2LlNpdXudtbzLnfTTUBqkaW18VqOrkmhK7uRMe-UbF6Ia_lvyNHlFSmT64MjIwhEw786Wc7DknouSg-aHJPsuSWYVfjegQRsFMbZZudpjilKv3k9_hxgccc28E06Aidgq01kM1krr2cP9mmqU8z35MY1KcbU2L4klaFiaPTeviZbFGz24DMMUgj_fHhFCff77tMBP8y-lFIKf7bezH8NZgPahH1xV6JGLPhVBv0L3S4rdfZwvh6cjX3BdIu16hFwGiqaq7-LxbpT8fecsuRfIViretFeDx8JOXFKADrYKF_KJreyJDojmiD5DUlYSwlF9RErOlG8XH1qRB2BiA4QYP2Q7Jhd_A4pdlKlS57Cw69hvSbXV9aQNpGWocPqql1sfIvwTWslHQHR084E0vbKjoBm1XeNNuCUkZsSjryDVCiNx34mi71w27w_olzACU3ikOCjzqWv-JTDTi7m_LRMETkL9XNvhNwaqgg1DFBYeq8tcJCa-ju9yeTuQLHi2xlE1OBaktanAsatyH1XxMV8JwRyOQM0PmWEIajPFlw0uPsl3Jsv5gwCxUZ7HbJjnoqaY30GcI_CRfRHFdKadBaZuNA5ij5tYSEPrB3T-bJ-0F3M4O_CMppb1uP3vxO1mSbFDT19bgkbdlCixWS_vNDszcK-8eUGZaAX8ykHjqPQuTU3YLpu4x5t-Sj8wZlHyHCdYC0hp0YwrA_BNx8QKBXrY8MackI0oOYqBif6YPcTG44KZZ8puYckVndhwwg7REwIfHjuOJTpbYiZVNS05cGK3R-iriu8L8bFXa54El-s0D7pK9uqtt99sJwgjZb1m2XYTd0m4F8RP1BLlImU0YWLC_v-wgH5eiaz7hk4YKUw6-1otbAh1L4f_nCHn_O_0fm-YPmAr4w31y5nsLG-nMs8MZuQRdco4M_HwNnypZ3sW0lRqmIfM-U2u1YRaV43zxIP3GqYS-Qu0mu_o-QG_I3_yiUoyxjMOaGctU3CY-43r-aHKuMBdkm9zbDMe6PDv_bcAibs5bWY_OkFBuEHDpq1PD34TQ826kJ5SE1bsnBvICDOWbX1GfZluhWzerSWfa1oEi4q-FMFbrfTBDQ3vJrcZ7CJaBL-6gWtLWlQGx0vhUxDE6Q_Gi9TV1q5EYab_i1XEnVE5E4UKVfZK3pYGyWalK7DcVjCgnZh3JmTKbf5eVg0pZN2kCFjwRsX0fUJTiHIRlFficbwKgeWDdPqZc1O3wOAsM0z_f4Yj6CgOsob5zwZJ0CTxHTGb7gfTqPMc_YIOAANUikc16kdbvxmd6947wB04CCcVrf44n4YTvDs9fyY5_NPb3CDpFEGftEtssk50XrFVA6p0vin3PtdCEExibxul2KKFge7gRJp2s4nHx_iIx1igbu29hgwuvdjiFN2GzRMlC1hFgeueEdwJWWeB7k9DE14revWV2MUGeZXmB8Yg-S7M9rws2pNE7E38iDOQveY-OExIWQvmNleMCX-MWPnhHfZIMIRUvIby1i3JlZZnhoQctHVJ9IAiewQmnURD_9fb-SWXIkMgVh3U9TpFtn4iDKFTwX-lyM0zKUfCs1d-k2o5mlTGOjoc4n80eG_oQSWRZ5N8iul8M_5OFAOliuK0sxL0NoZfdWwwEePMjn4FL3xaUwMR3SHtDI2asq1lQN1cdVn38-cBJmbWbk94L4zch5A00sV3WP9js1nCC_vcju5-BC70_ZypXXKjL5-uzI3RysWLAlFZO2ZE8zj6yCCxj80mixHSbtKpSDG39aOUbg6pjK8lBesMG-QYQwCZ2ZYAerl1C-wXIoCi2B25BPWLosZodvJC8aexwOOKWc0zHpHNbF2vmijaVIE7FehsEzP_SI8yd__Af9c5A5T-hRfmXZw2iMJk9JreAjEyO-kQZkdASbbEwhpRHJWWcH1Ivgx5sn9S2SaJKWZbNR9SzWSNEqS1Da_79cKT8DXqyq4yCnFt7CXX19p2p2Yd-Sp_9DTqouivThBJPk-ijzljluTFC5n4Ha_DQB85zMaYKBtriVNzA3ToBjGO6KmzsHu4xaP5Bqp_0unc7DWH_AtBI15suNkvMIbLPDUL6erpQIluFjnxBGtv4Pxmtizk4hWll7Sz0lXmAF-c4p5HlDHfwYzTDin9M8yJ3p6NiPbjOhg7sxYjfsGRdpLvA78ZYGaZpU62k9ZouAAGp1O7MMwgEoQRFiksW2mA0Kj2d7Kzba-ezRLGdGeJRDl7Bh3WLQ6ZK12nu5KlcbH5acKy_aTYU46Ui1ubz2Q-2g3tlDLStDm9bOta_Qc2iOX8igPSyE8h0tb74ZAm9GVv3Wg_JMvcOvY0uOQTg-ys4mbbFo-E8F_jno1Q389_OqZ5VmTr4b_u_zdEh3aYHEW67bACTeqgfwtb7wH4l-MaCwNgJfyvnvbP5GMXNqthzCntm-rfdXRA-K1cjSNn0LC9wnGhMC3iLqJbJKfXOXeMyUL6l8g_nux29eRxUv2Bc9TAv1_-ltbIAyNiawzeZKw9XYGUP4YLll9tMpoQaj8GlKo3s9j9KuGrTMn8qZBEEemtakm1DC4pLQL4Zt5mupn79y_B1jYk74jWz6xvbfeRSt4j2xIzXggdfvMDIYACQ5y-4PKc72pLAN3JjkHmYT_LHc7K7emkknHL-YFI7Nl7f6WA87JbLn0csg4SLyiJmlaadqx0LhZUZTr89DN8I23JUgHFo56x7MrAbOM7yVw4Lokd6i5_6QGYM_M5X9FklnRLM43-sOpDLAIgsgIRN0W65EUNYlp73WbHce_dUSFXNnz5JtFv_BORlmjMDZ_0qSXcYlop17R3OL_wyuYlMvtq17tYQcl7S0kewyX_9kuASnL2a8ht0UIpp7OuPwvUCXSIWwmdlaULT3mSJ-n8NHB_uTg00-JxjCRiEsKVlRkTJ1qRfY4qf86x-aiV59I0S1eUfQH1t4jsKYcVu3dKDW0jj_x6nIXfEg-sS3Do4EWvvZqrcjM1RE9sHaz3TVcCwbvTuLjEiEuAUwExF-5CS9kdW5TVRy6pN9es6gNKvUU7NY2QjIQg_LUSMtaA73Bj86BsGnQE7jC1Xlgv5YW97mi5n1hskqZzecycyCYXeeDaE_vYKOUU47wZA7LEdUYIQwcgZNuLpYbf9MKSHk2T-PyaCLiZ__y8nDcfvSHNChBM-E-HI2hbsuH5Zbq7wCZ7ZPHrcl68iSFVzNDlNgQsTSuTo9i5uzWT0y8xU3p1VmnC8Ayo298kYiNaTSzX0N5lX3sQcp8UTgdzfT8R99dpQgEWuwjBwOsvTJbyk_cOXhkMWCjLIQLnI47SsUqmeO9TQ9BZNu0a3UbnLVgqb3Url2NJxTG9FGTpUd4uQ3ebfELsF-7sZGa1CGI5iPH_qoeOHuffJxCqe-gAmERI-4VCSXcmKhznCLnloj36vwpVrUD871YkuxV59nxNgYiPdg3MykxQZYnaOjanDt5WLUbR-xS_EJyD7ndnjfP4MnTgeo5XiHGoqE3K5BaIj2S1G1tU6jivaVrN1HWZ6KnRkTb6wEsf1g_AS5I4Mg43HNdkHS8WDT2tMkkLZDqvsTPLp2BF43nrDp77YfxsmJFUqYlaiI3zrwtumby3TaaXYEgV2MP9dkoupiXF02yaz9Ntq6_IIl87prlVRD0GK_shuVKfzYhDm2YFOo0VyW-gv2jKkF6WZ97LIkmlqwsLiH8PwXgUYOv-XdV4GrnV4vA3IX7EbXhZCzPU0u9tvm01oq_7SDpO6PV4cIDWfJT22iTis6DH0CB6YDw6lOsbkY16usgTHEy5vHL0iEs6-Sp1rC-Kk-iNI1llNAVKkc4TZ0TD1tAjfe9dt1O5gbuPpFOKQ-el1yarJIsS70qaKpyleHCS5FsLhh4peKv5SbJiBQ1-VEa0JJjKBPSiz9uKAACrnnNN8UlW4lUxpxDHpgsd-nXaA6hsDH4f75aX15vT_zWsIW7T76vGcblU9x64RIUQFRdEAxiAdrp5djv1ZJIkrWtMLm1mEevGc2EFL9F8O5sKfeWmAPo4LqhkOw6OO1E0upcamWJJqFZmid5_eFMXrRcl3LbCNV68aUsTPimwSrdqbhMcIJuVfVyi9oo7LOV9XNrhYkyg0Jv86PPkOnKEzKxiJ0CZXs7YZT-LVNfCDe0Ab5EtzVEV_ifAjVfBGtVsImS_1l0J6-bl01NTpLBwN8BxO0_T8u4EPP7Q9zZjz_lk3-cXwcCsvCSVoj3Z0YJpuxM HTTP 307
  • https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D

14 HTTP transactions

Resource
Path		 Size
x-fer		 Type
MIME-Type
ClinicalTrials
www.cvs.com/
Redirect Chain
  • https://protect-us.mimecast.com/s/MWdhCR6DLGfgWwgRvC28OCb?domain=cvs.com
  • https://protect-us.mimecast.com/r/p3E_Wxk4Yyc4ABacMaXxxhgghMNAQbgj43QIubHyxzhtHeAyYDJ5WRhiC5miOfN3rTNl8U19xj6ZNZo6PmEqpzUPhR9Ryv86Yi0mjjp3QRYfFI3S62WvsOt3zcLd0qrngAgakHab4IR6GMuvoMaGjgk3aHaJEKWm-H6...
  • https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
19 KB
8 KB 		Document
General
Check archive.org
Download Go to
Full URL
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
dddf9fc4f70b3f41d27b95244ba29116e9c5bb1d92e5ecad79f47486f8fcee1a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=0, no-cache, no-store
content-encoding
gzip
content-length
4407
content-type
text/html
date
Wed, 02 Nov 2022 09:44:12 GMT
expires
Wed, 02 Nov 2022 09:44:12 GMT
last-modified
Fri, 25 Jun 2021 15:25:54 GMT
permissions-policy
interest-cohort=()
pragma
no-cache
strict-transport-security
max-age=31536000 ; includeSubDomains
vary
Accept-Encoding
x-akamai-transformed
9 4337 0 pmb=mTOE,1
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-req
1,a-use-ut,1667382251,23.49.249.196:b83b3d,207.126.118.231
x-xss-protection
1; mode=block

Redirect headers

Cache-control
no-store
Connection
keep-alive
Content-Length
0
Date
Wed, 02 Nov 2022 09:44:11 GMT
Location
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Pragma
no-cache
Strict-Transport-Security
max-age=31536000; includeSubDomains; preload
X-Robots-Tag
noindex, nofollow
moment.min.js
www.cvs.com/bizcontent/clinicaltrials/ 		57 KB
19 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.cvs.com/bizcontent/clinicaltrials/moment.min.js
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
602eb5c4c25c5a06b0fa60cbe793ae493f132f8d82304505365cd008cc55d77b
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN, SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36

Response headers

date
Wed, 02 Nov 2022 09:44:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000 ; includeSubDomains
content-length
18613
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Fri, 12 Feb 2021 17:12:34 GMT
x-req
1,a-use-ut,1667382252,23.49.249.196:b83b75,
x-frame-options
SAMEORIGIN, SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=0, no-cache, no-store
permissions-policy
interest-cohort=()
accept-ranges
bytes
expires
Wed, 02 Nov 2022 09:44:12 GMT
moment-timezone-with-data.min.js
www.cvs.com/bizcontent/clinicaltrials/ 		191 KB
29 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.cvs.com/bizcontent/clinicaltrials/moment-timezone-with-data.min.js
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
d5ff1e7ab48644f9634dcafe79f3c7a9f9c45e62ba751eaf8f2951f84bfea3b5
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN, SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36

Response headers

date
Wed, 02 Nov 2022 09:44:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000 ; includeSubDomains
content-length
29635
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Fri, 12 Feb 2021 17:12:34 GMT
x-req
1,a-use-ut,1667382252,23.49.249.196:b83b76,
x-frame-options
SAMEORIGIN, SAMEORIGIN
vary
Accept-Encoding
content-type
application/javascript
cache-control
max-age=0, no-cache, no-store
permissions-policy
interest-cohort=()
accept-ranges
bytes
expires
Wed, 02 Nov 2022 09:44:12 GMT
CVS-spinner.gif
www.cvs.com/bizcontent/clinicaltrials/ 		26 KB
26 KB 		Image
General
Check archive.org
Download Go to Show image
Full URL
https://www.cvs.com/bizcontent/clinicaltrials/CVS-spinner.gif
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
Akamai Image Manager /
Resource Hash
be32e56c4caac7c39913c798a39d8ca5edacbfcca52fdf9a363b34e4b942e92a
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36

Response headers

date
Wed, 02 Nov 2022 09:44:12 GMT
strict-transport-security
max-age=31536000 ; includeSubDomains
last-modified
Sun, 30 Oct 2022 07:22:04 GMT
server
Akamai Image Manager
x-req
1,a-use-ut,1667382252,23.49.249.196:b83b7c,10.49.249.173
content-type
image/gif
cache-control
private, no-transform, max-age=43200
content-length
26236
expires
Wed, 02 Nov 2022 21:44:12 GMT
AD8B
www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/ 		188 KB
73 KB 		Script
General
Check archive.org
Download Go to
Full URL
https://www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/AD8B
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
3b73f1cda76daf8b9987f18afd1febfe801ef8c98b8ae1beb927afbad02c1b5c
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

accept-language
en-US,en;q=0.9
Referer
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36

Response headers

date
Wed, 02 Nov 2022 09:44:12 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31536000 ; includeSubDomains
content-length
74036
x-xss-protection
1; mode=block
pragma
no-cache
last-modified
Tue, 13 Sep 2022 17:56:26 GMT
etag
"b363f2fa7449f519258aa42fe218ce38fe6c3a875df288ced7e899b7f99ccafc"
x-req
1,a-use-ut,1667382252,23.49.249.196:b83b7b,
vary
Accept-Encoding
x-frame-options
SAMEORIGIN
content-type
application/javascript
cache-control
max-age=21600
permissions-policy
interest-cohort=()
expires
Wed, 02 Nov 2022 09:44:12 GMT
1.0.0
depservices.cvs.com/dep/memberevents/publishmemberevents/ 		65 B
1 KB 		XHR
General
Check archive.org
Download Go to
Full URL
https://depservices.cvs.com/dep/memberevents/publishmemberevents/1.0.0
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/ Express
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31104000 ; includeSubDomains
X-Content-Type-Options nosniff

Request headers

Accept
application/json
Referer
https://www.cvs.com/
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36
Content-Type
application/json

Response headers

geolocation
georegion=274,country_code=US,region_code=NY,city=NEWYORK,dma=501,pmsa=5600,msa=5602,areacode=212,county=NEWYORK,fips=36061,lat=40.7500,long=-73.9967,timezone=EST,zip=10001-10014+10016-10041+10043-10045+10055+10060+10065+10069+10075+10080-10081+10087+10090+10095+10101-10126+10128-10133+10138+10150-10179+10185+10199-10200+10203+10211-10213+10242+10249+10256-10261+10265+10268-10282+10285-10286+10292,continent=NA,throughput=vhigh,bw=5000,asnum=9009,location_id=0
date
Wed, 02 Nov 2022 09:44:13 GMT
content-encoding
gzip
x-content-type-options
nosniff
strict-transport-security
max-age=31104000 ; includeSubDomains
x-cdn
Imperva
x-powered-by
Express
x-iinfo
12-23521838-23521839 NNYN CT(55 112 0) RT(1667382252324 1) q(0 0 1 0) r(2 2) U5
max-forwards
20
content-length
77
pragma
no-cache
x-correlationid
Id-ed3b62636925e846c4629f31 0
etag
W/"41-KPjsxI2omhBD06W80Xb724MR65E"
x-req
allow-use-ut,1667382252,23.49.249.196:b83bc2,104.114.79.59,none
vary
Accept-Encoding
clientaddr
NA
content-type
application/json
access-control-allow-origin
https://www.cvs.com
access-control-allow-methods
Get,Post,Head,Put,Delete,Options
access-control-expose-headers
x-correlationid
cache-control
max-age=0, no-cache, no-store
access-control-allow-credentials
true
access-control-allow-headers
env,grid
expires
Wed, 02 Nov 2022 09:44:13 GMT
1.0.0
depservices.cvs.com/dep/memberevents/publishmemberevents/ 		0
0 		Preflight
General
Check archive.org
Download Go to
Full URL
https://depservices.cvs.com/dep/memberevents/publishmemberevents/1.0.0
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31104000 ; includeSubDomains
X-Content-Type-Options nosniff

Request headers

Accept
*/*
Access-Control-Request-Headers
content-type
Access-Control-Request-Method
POST
Origin
https://www.cvs.com
Sec-Fetch-Mode
cors
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36

Response headers

access-control-allow-credentials
true
access-control-allow-headers
content-type
access-control-allow-methods
Get,Post,Head,Put,Delete,Options
access-control-allow-origin
https://www.cvs.com
allow
OPTIONS, POST
cache-control
max-age=0, no-cache, no-store
content-length
0
content-type
text/plain
date
Wed, 02 Nov 2022 09:44:12 GMT
expires
Wed, 02 Nov 2022 09:44:12 GMT
pragma
no-cache
strict-transport-security
max-age=31104000 ; includeSubDomains
x-cdn
Imperva
x-content-type-options
nosniff
x-correlationid
Id-ec3b62638d496bdbb90d786d 0
x-iinfo
5-6889463-6889464 NNNN CT(54 111 0) RT(1667382252070 0) q(0 0 2 0) r(2 2) U5
x-req
allow-use-ut,1667382252,23.49.249.196:b83b8b,104.114.79.59,none
AD8B
www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/ 		18 B
974 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/AD8B
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/AD8B
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
bef9393fcdfc7a7299c058ba2a69253c32e0964dd3e97834e17a8cdb5dce7cf6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Wed, 02 Nov 2022 09:44:12 GMT
strict-transport-security
max-age=31536000 ; includeSubDomains
x-content-type-options
nosniff
x-req
1,a-use-ut,1667382252,23.49.249.196:b83b88,127.0.0.1
vary
Origin
x-frame-options
SAMEORIGIN
content-type
application/json
access-control-allow-origin
https://www.cvs.com, www.cvs.com
access-control-allow-credentials
true
permissions-policy
interest-cohort=()
x_req_id
09905cab-59b7-4985-98c4-28e98d26d3d8
access-control-allow-headers
Content-Type
content-length
18
x-xss-protection
1; mode=block
AD8B
www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/ 		18 B
959 B 		XHR
General
Check archive.org
Download Go to
Full URL
https://www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/AD8B
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/VEu-zx3HWpYFO8DfSw/Q3huXtSbEm/EGtHdV0efQs/WU8JXAYZ/AD8B
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
bef9393fcdfc7a7299c058ba2a69253c32e0964dd3e97834e17a8cdb5dce7cf6
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
accept-language
en-US,en;q=0.9
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36
Content-Type
text/plain;charset=UTF-8

Response headers

date
Wed, 02 Nov 2022 09:44:12 GMT
strict-transport-security
max-age=31536000 ; includeSubDomains
x-content-type-options
nosniff
x-req
1,a-use-ut,1667382252,23.49.249.196:b83bc8,127.0.0.1
vary
Origin
x-frame-options
SAMEORIGIN
content-type
application/json
access-control-allow-origin
https://www.cvs.com, www.cvs.com
access-control-allow-credentials
true
permissions-policy
interest-cohort=()
x_req_id
055d71d7-e5fd-48b5-920a-3956627e0a11
access-control-allow-headers
Content-Type
content-length
18
x-xss-protection
1; mode=block
Primary Request %7B%7BstudyURL%7D%7D
www.cvs.com/ 		9 KB
0 		Document
General
Check archive.org
Download Go to
Full URL
https://www.cvs.com/%7B%7BstudyURL%7D%7D
Requested by
Host: www.cvs.com
URL: https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Protocol
H2
Security
TLS 1.3, , AES_256_GCM
Server
23.205.60.109 Edison, United States, ASN16625 (AKAMAI-AS, US),
Reverse DNS
a23-205-60-109.deploy.static.akamaitechnologies.com
Software
/
Resource Hash
Security Headers
Name Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block

Request headers

Referer
https://www.cvs.com/ClinicalTrials?studyURL=%7B%7BstudyURL%7D%7D&opportunityID=%7B%7BopportunityIS%7D%7D&campaignID=%7B%7BcampaignIS%7D%7D
Upgrade-Insecure-Requests
1
User-Agent
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/107.0.5304.87 Safari/537.36
accept-language
en-US,en;q=0.9

Response headers

accept-ranges
bytes
cache-control
max-age=0, no-cache, no-store
content-length
9387
content-type
text/html
date
Wed, 02 Nov 2022 09:44:25 GMT
expires
Wed, 02 Nov 2022 09:44:25 GMT
last-modified
Fri, 05 Sep 2014 01:15:34 GMT
permissions-policy
interest-cohort=()
pragma
no-cache
strict-transport-security
max-age=31536000 ; includeSubDomains
x-content-type-options
nosniff
x-frame-options
SAMEORIGIN
x-req
1,a-use-ut,1667382253,23.49.249.196:b83be1,208.185.54.17
x-xss-protection
1; mode=block
common.css
www.cvs.com/webcontent/css/ 		0
0
balance.css
www.cvs.com/webcontent/css/ 		0
0
jquery-1.4.3.min.js
www.cvs.com/webcontent/js/ 		0
0
cvs-logo.png
www.cvs.com/webcontent/images/common/ 		0
0

Failed requests

These URLs were requested, but there was no response received. You will also see them in the list above.

Domain
www.cvs.com
URL
https://www.cvs.com/webcontent/css/common.css
Domain
www.cvs.com
URL
https://www.cvs.com/webcontent/css/balance.css
Domain
www.cvs.com
URL
https://www.cvs.com/webcontent/js/jquery-1.4.3.min.js
Domain
www.cvs.com
URL
https://www.cvs.com/webcontent/images/common/cvs-logo.png

Verdicts & Comments Add Verdict or Comment

9 JavaScript Global Variables

These are the non-standard "global" variables defined on the window object. These can be helpful in identifying possible client-side frameworks and code.

object| onbeforeinput object| oncontextlost object| oncontextrestored function| structuredClone object| launchQueue object| onbeforematch function| getScreenDetails function| queryLocalFonts object| navigation

69 Cookies

Domain/Path Name / Value
www.cvs.com/ Name: aat1
Value: off-p0
www.cvs.com/ Name: aat4
Value: off-p2
www.cvs.com/ Name: adh_ps_pickup
Value: on
www.cvs.com/ Name: adh_ps_refill
Value: on
www.cvs.com/ Name: buynow
Value: off
www.cvs.com/ Name: cp_new_dash
Value: off
www.cvs.com/ Name: sab_displayads
Value: on
www.cvs.com/ Name: dashboard_v1
Value: on
www.cvs.com/ Name: disable-app-dynamics
Value: on
www.cvs.com/ Name: dpp_cdc
Value: off
www.cvs.com/ Name: dpp_drug_dir
Value: off
www.cvs.com/ Name: dpp_sft
Value: off
www.cvs.com/ Name: easy_xfer
Value: off
www.cvs.com/ Name: enable_imz
Value: on
www.cvs.com/ Name: enable_imz_gs
Value: on
www.cvs.com/ Name: enable_imz_notimeslot_cache
Value: on
www.cvs.com/ Name: enable_imz_reschedule_instore
Value: on
www.cvs.com/ Name: enable_imz_reschedule_multiplendc
Value: off
www.cvs.com/ Name: enable_imz_reschedule_clinic
Value: on
www.cvs.com/ Name: footer_new_V1
Value: on
www.cvs.com/ Name: gbi_cvs_coupons
Value: true
www.cvs.com/ Name: gbp_api_v2
Value: on
www.cvs.com/ Name: imz_onestr
Value: on
www.cvs.com/ Name: mc_cloud_service
Value: on
www.cvs.com/ Name: mc_hl7
Value: on
www.cvs.com/ Name: mc_videovisit
Value: on
www.cvs.com/ Name: newauthflow
Value: on
www.cvs.com/ Name: ps_i
Value: on
www.cvs.com/ Name: rxdanshownba
Value: off
www.cvs.com/ Name: rxdfixie
Value: on
www.cvs.com/ Name: rxd_bnr
Value: on
www.cvs.com/ Name: rxd_dot_bnr
Value: on
www.cvs.com/ Name: rxdpromo
Value: on
www.cvs.com/ Name: rxduan
Value: on
www.cvs.com/ Name: rxm_ph_dob
Value: on
www.cvs.com/ Name: rxm_demo_hide_LN
Value: off
www.cvs.com/ Name: rxm_rx_challenge
Value: off
www.cvs.com/ Name: rxmsecques
Value: on
.cvs.com/ Name: rxtiemm
Value: on
www.cvs.com/ Name: rxuntiesb
Value: off
www.cvs.com/ Name: s2c_beautyclub
Value: on
www.cvs.com/ Name: s2c_cmxadc
Value: on
www.cvs.com/ Name: s2c_rewardstrackerbctile
Value: on
www.cvs.com/ Name: s2c_rewardstrackerbctenpercent
Value: on
www.cvs.com/ Name: s2c_rewardstrackerdob
Value: off
www.cvs.com/ Name: sft_mfr_new
Value: on
www.cvs.com/ Name: sftg
Value: on
www.cvs.com/ Name: show_exception_status
Value: on
www.cvs.com/ Name: slistview
Value: on
www.cvs.com/ Name: sl_v2
Value: off
www.cvs.com/ Name: sub_api_v2
Value: on
www.cvs.com/ Name: sub_cp_fmf
Value: on
www.cvs.com/ Name: sub_v2
Value: off
.cvs.com/ Name: untieLegacyRx
Value: on
.www.cvs.com/ Name: akavpau_www_cvs_com_general
Value: 1667382672~id=d9571ff1c4e5b84e6696247d6d2b7948
www.cvs.com/ Name: hmnew
Value: on
www.cvs.com/ Name: geth
Value: off
.cvs.com/ Name: hdnew
Value: on
www.cvs.com/ Name: gr
Value: g2
www.cvs.com/ Name: gb
Value: g3
www.cvs.com/ Name: pdpr
Value: on
www.cvs.com/ Name: ga
Value: g3
www.cvs.com/ Name: rxe
Value: i1
www.cvs.com/ Name: mcpe
Value: gr
.cvs.com/ Name: pe
Value: p1
www.cvs.com/ Name: acct_pe
Value: p1
.cvs.com/ Name: ak_bmsc
Value: A0781B70B968E1410F42E38FF3ED41F0~000000000000000000000000000000~YAAQxPkxFyxVIjKEAQAAhxO6NxHhJX5jPF/rE3yBPWE6vBGwRK6P7cEWoHfM4/6jrL9IdkgsvT43B5dyLAqfbF5e6G4T34+6VFruhn7jFYzI03s7rVP3PhFt66Roho5EKGUxh3vNvWJzWe/thhlbWAzaRKj+kMDa6d6pWBRJnF7Y5AxCegrDrkRmmC6kJSlm02nC8qP1rC9qShXTpS2ow4s1z3SXmk8Oo61Ah0pdlG1wHqhAzrrRiaLNMFX4jhzgsPgxFRQ/KLCseeHS/yZRd3Pa/XH/zv599xH601mwFKwY52HH+KQJKe4VW5rCIV/Nbjd1QlLxZqGlbmtmfKTCt4R4vnzTkeF0UE7OH5hkP+1kt28jX3bC6zXo9zJOReT2TmW81UAlPw==
.cvs.com/ Name: bm_sz
Value: BB6676A4BC23347ACF642589D228D058~YAAQxPkxFy1VIjKEAQAAhxO6NxF7VV4bzA1HHIOzTj7Yom2sSkIvEHiNUgy2oAY9PNQOxDvBG/4aH1na3/Cm/uENAIlX5KtB1qlKV+CzGfWRgnoSAxt+uVKf/Hhh2f2AP75uXO2Dtu5WdwDiDPenTEMtbM9NpUDzOHKY4ZZCh5hCr2iwRs405GvOxA/gX9J7PEFUub5hoahOU9qKJ+ECghz8Oj723CgfcYMWM48db+z0Xt1MIFDdJI7XGP8GijY1hQv03bRedvtwkJ5R7rtvrQZUOYU3g7ADy5Oo9vzwwUs=~4342597~3622453
.cvs.com/ Name: _abck
Value: 981727666A063EAF4AD0CC4572A3CAF9~0~YAAQxPkxFz5VIjKEAQAAhRW6NwiaqE2A9X6nUfPxwIyX0/I84WCntVG3SVUIluwfYgJADVfH9tTLRvQkxWGOue236RFCLST9L7QajpGDBzjg8hSRU8lc+aB++T826x44arOYmZEpOtOjBvOGu7ZJYS7qhsBAYAd01lt5eDwa7ygunKI+wfuMqsMGOslUKr/80BZ7XJmnfjlDLScJebohsah/A3QKm4suqnI/L/uvTV9KsI3n6Z74XcyGh1AfuzdQKeXQN0YRf96Zmi/To8yf0zsNkCPHlezgLx+RnRTuxK3UxlbODntOCA6h/1GxyVRSEG31NYDUOYb8Gott2OXYl8x3SXiAvc8kkkGYP9elVUY+c0hcBnCBVVzqb1HD2d4dHd2TqClTpSoWfV71I4pi+6SIIxpj~-1~||-1||~-1

3 Console Messages

Source Level URL
Text
security warning
Message:
Error with Permissions-Policy header: Origin trial controlled feature not enabled: 'interest-cohort'.
security warning
Message:
Error with Permissions-Policy header: Origin trial controlled feature not enabled: 'interest-cohort'.
network error URL: https://www.cvs.com/%7B%7BstudyURL%7D%7D
Message:
Failed to load resource: the server responded with a status of 404 ()

Security Headers

This page lists any security headers set by the main page. If you want to understand what these mean and how to use them, head on over to this page

Header Value
Strict-Transport-Security max-age=31536000 ; includeSubDomains
X-Content-Type-Options nosniff
X-Frame-Options SAMEORIGIN
X-Xss-Protection 1; mode=block